Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Designed Multiple Ligands for Cancer Therapy

3 Oct 2011

Abstract excerpt

The concept of a single chemical entity with desirable activity at more than one biological target is an attractive one. Increasingly, multiple complex biochemical pathways are implicated in a variety of diseases including cancer. Successful treatment of these conditions often depends on pharmaceutical intervention at multiple pathways, with a combination of different drugs. Designed multiple ligands (DMLs) are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Breast Cancer Therapies
Share to Biochemical and Molecular Research
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21919848
DOI: 10.2174/092986711797535344

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Designed Multiple Ligands for Cancer TherapyPMID 21919848Read ↗

Kinase Inhibitors in Multitargeted Cancer TherapySemantic proximity Read ↗

Synthetic and Naturally Occurring Heterocyclic Anticancer Compounds with Multiple Biological TargetsSemantic proximity Read ↗

Plant derived secondary metabolites as multiple signaling pathways inhibitors against cancerSemantic proximity Read ↗

Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and ProgressionSemantic proximity Read ↗

Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review.Semantic proximity Read ↗

Molecular Target and Action Mechanism of Anti-Cancer AgentsSemantic proximity Read ↗

Targeted Therapies in Cancer: To Be or Not to Be, SelectiveSemantic proximity Read ↗

[Recent developments in targeted therapy for cancers and drug discovery].Semantic proximity Read ↗

Tyrosine kinase inhibitors and their unique therapeutic potentialities to combat cancer.Semantic proximity Read ↗

Two targets are better than one. Promising combination therapy to treat breast cancer.Semantic proximity Read ↗

An overview of targeted cancer therapySemantic proximity Read ↗

A Methodological Workflow to Analyze Synthetic Lethality and Drug Synergism in Cancer Cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.